ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00964704
Brief Title: A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

First Submitted : August 21, 2009
First Submitted that Met QC Criteria : August 24, 2009
First Posted : August 25, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2016
Last Update Posted : November 2, 2016 (Estimate)